MOBERG PHARMA AB (MBGPF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 46 sessions, September 5, 2025 to September 8, 2026
- Largest daily move
- +16.7% close of November 6, 2025
- 1-year change
- +16.8% closing prices, September 5, 2025 to September 8, 2026
Company Description
MOBERG PHARMA AB (OTC: MBGPF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $53.1M.
MBGPF has gained 16.8% over the past year. The last closing price was $1.11.
This page collects what Stock Titan holds for MBGPF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
MOBERG PHARMA AB (MBGPF) closed at $1.11 on September 8, 2026. Over the past 12 months, the price has gained 16.8%.
MBGPF Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
MOBERG PHARMA AB has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all MBGPF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in MOBERG PHARMA AB (MBGPF) currently stands at 6.0 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for MOBERG PHARMA AB (MBGPF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
MBGPF Company Profile & Sector Positioning
MOBERG PHARMA AB (MBGPF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MBGPF often look at related companies in the same sector, including Eagle Pharmaceut (EGRX), Healthy Extracts Inc (HYEX), Leef Brands (LEEEF), C21 Investments (CXXIF), and Rubicon Organics (ROMJF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MBGPF's relative position within its industry.